Neuropace Inc — Quarterly Financial Statistics (NASDAQ:NPCE) | MetaTrader

Open full chart

Financials

Overview Rapor Statistics

Quarterly Annual

Cash from operating activities -4.8 M-7.48 M-2.09 M-1.94 M506 K -11.01 M Cash from investing activities 1.96 M-37 K-168 K-30 K-97 K -332 K Cash from financing activities 848 K21.11 M-1.91 M-235 K635 K 19.6 M Free cash flow -4.84 M-7.52 M-2.25 M-1.97 M409 K -11.34 M

Haberler

Key Catalysts That Will Likely Drive Prospects for NPCE Stock in 2026

NPCE RNS System Explained: Growth Drivers and Setup for 2026

NeuroPace's Seizure ID and New Indication Could Expand RNS Demand

Neuropace CMO 399 bin dolarlık hisse sattı

Neuropace (NPCE) chief medical officer sells $399k in stock

NeuroPace, Inc. (NPCE) Q4 2025 Earnings Call Transcript

NeuroPace, Inc. (NPCE) Reports Q4 Loss, Beats Revenue Estimates

NeuroPace hisseleri 4Ç geliriyle tahminleri aştı, %15 yükseldi

NeuroPace beats estimates as Q4 revenue surges 24%, sending shares up 15%

Neuropace kazancı $0,10 ile beklentilere göre daha iyi, kâr ise beklentilere göre yüksek

Neuropace earnings beat by $0.10, revenue topped estimates

LivaNova (LIVN) Tops Q4 Earnings and Revenue Estimates